Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.9 CHF | -0.28% | +0.45% | +9.63% |
08:07am | NOVARTIS AG : Berenberg remains Neutral | ZD |
06:01am | Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.63% | 208B | |
+38.11% | 723B | |
+34.52% | 595B | |
-2.79% | 369B | |
+20.65% | 332B | |
+2.33% | 282B | |
+17.28% | 244B | |
-4.50% | 205B | |
+0.17% | 168B | |
+7.32% | 166B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Berenberg Lowers Price Target on Novartis, Maintains Buy Recommendation